These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25099851)
1. Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes. Maher ER Clin Med (Lond); 2014 Aug; 14(4):440-4. PubMed ID: 25099851 [No Abstract] [Full Text] [Related]
2. Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations. Choi Jdo W; Tucker KM; Lee TT; Chong GC Head Neck; 2014 Oct; 36(10):E99-E102. PubMed ID: 24375508 [TBL] [Abstract][Full Text] [Related]
3. Multifocal Paraganglioma and Pheochromocytoma Due to Truncated SDHD Mutation. Zuo Y; Li X; Wu X; Zhou J; Wang J; Wang J; Wu Z; Li H; Zhang X Urology; 2018 Jun; 116():63-67. PubMed ID: 29545045 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639 [TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851 [TBL] [Abstract][Full Text] [Related]
6. No child left behind in SDHB testing for paragangliomas and pheochromocytomas. Schiffman JD J Clin Oncol; 2011 Nov; 29(31):4070-2. PubMed ID: 21969491 [No Abstract] [Full Text] [Related]
7. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Papathomas TG; Oudijk L; Persu A; Gill AJ; van Nederveen F; Tischler AS; Tissier F; Volante M; Matias-Guiu X; Smid M; Favier J; Rapizzi E; Libe R; Currás-Freixes M; Aydin S; Huynh T; Lichtenauer U; van Berkel A; Canu L; Domingues R; Clifton-Bligh RJ; Bialas M; Vikkula M; Baretton G; Papotti M; Nesi G; Badoual C; Pacak K; Eisenhofer G; Timmers HJ; Beuschlein F; Bertherat J; Mannelli M; Robledo M; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger RR Mod Pathol; 2015 Jun; 28(6):807-21. PubMed ID: 25720320 [TBL] [Abstract][Full Text] [Related]
8. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma. Dona M; Neijman K; Timmers HJLM Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747 [TBL] [Abstract][Full Text] [Related]
9. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324 [TBL] [Abstract][Full Text] [Related]
11. SDH-related pheochromocytoma and paraganglioma. Kantorovich V; King KS; Pacak K Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333 [TBL] [Abstract][Full Text] [Related]
16. Risk of metastatic pheochromocytoma and paraganglioma in Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053 [TBL] [Abstract][Full Text] [Related]
18. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Gimm O; Armanios M; Dziema H; Neumann HP; Eng C Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372 [TBL] [Abstract][Full Text] [Related]
19. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. King KS; Prodanov T; Kantorovich V; Fojo T; Hewitt JK; Zacharin M; Wesley R; Lodish M; Raygada M; Gimenez-Roqueplo AP; McCormack S; Eisenhofer G; Milosevic D; Kebebew E; Stratakis CA; Pacak K J Clin Oncol; 2011 Nov; 29(31):4137-42. PubMed ID: 21969497 [TBL] [Abstract][Full Text] [Related]
20. New advances in the genetics of pheochromocytoma and paraganglioma syndromes. Gimenez-Roqueplo AP Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]